Karyopharm signals $130M–$150M revenue target for 2026 with pivotal myelofibrosis data readout ahead
Karyopharm Therapeutics Inc. · PHARMACEUTICAL PREPARATIONS · Now $9.82
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS